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Introduction and objectives: Falls are one of the most common problems of hospitalized patients. 
Their occurrence is associated with many problems and therefore should be avoided. Effective 
prevention involves analyzing risk factors and implementing interventions to minimize these risks. 
The aim of this work was to analyze the influence of drugs and other risk factors on the fall of 
hospitalized patients. 
Methods: Data was collected from April to December 2017 in 4 hospitals in South Bohemia. Only 
patients who had fallen during hospitalization participated in the study. An online database was 
created for the study to collect patient data (personal history, medications used, laboratory values 
and others). Population and individual fall risk-increasing drugs were analyzed. For each individual 
fall risk-increasing drug, the type of drug problem that could have been the cause of a fall was 
classified. Risk minimization interventions have been assigned to each drug problem. In addition to 
fall risk-increasing drug analysis, other risk factors that increased the risk of falling as well as non-
falling drugs with some type of drug problem were considered. Data on each fall were recorded in 
a database, processed into tables and evaluated. 
Results: A total of 140 falls were evaluated in 136 patients (52.9 % in women, 47.1 % in men; 
average age 78 years). According to the 1. level of ATC classification, drugs affecting the nervous 
and cardiovascular systems were most commonly associated with the onset of fall. An increased 
risk of falling was most common with the antipsychotic agent tiapride (27.9 %) and the diuretic 
agent furosemide (33.6 %). Risks have also been identified for non-population fall risk-increasing 
drugs, namely metronidazole and quinolone antibiotics. The most common drug problem was the 
use of inappropriate drug due to the patient's age (32.6 %). Patient symptoms monitoring was the 
most commonly recommended intervention (37.1 %). 
Conclusion: In addition to commonly known fall risk-increasing drugs, the results also show groups 
that need to be given extra attention. Sufficient patient monitoring and more careful drug selection 
with a focus on patient individuality is important to minimize potential problems. 
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